Literature DB >> 9209461

Cytogenetics of primary testicular nonseminoma, residual mature teratoma, and growing teratoma lesion in individual patients.

J van Echten1, D T Sleijfer, J Wiersema, H Schraffordt Koops, J W Oosterhuis, B de Jong.   

Abstract

Residual mature teratoma (RMT) is often left behind when metastases of primary nonseminomatous germ cell tumors (NSs) are treated with chemotherapy. RMT is composed of fully differentiated somatic tissue. A growing teratoma (GTE) lesion may occur after (incomplete) resection of RMT. To shed light on tumor progression or the mechanism(s) of therapy related differentiation we investigated the chromosomal pattern of the primary NSs and RMTs in twelve patients, of the primary NS, RMT, and GTE lesion in one patient, and of the RMT and GTE lesion in two patients. Although several chromosomal differences are observed between the RMT and NSs and between the GTE and RMTs in the same patient, we obtained no evidence that specific chromosomal alteration(s) play a role in metastasis or differentiation.

Entities:  

Mesh:

Year:  1997        PMID: 9209461     DOI: 10.1016/s0165-4608(96)00284-1

Source DB:  PubMed          Journal:  Cancer Genet Cytogenet        ISSN: 0165-4608


  4 in total

1.  Detection of human endogenous retrovirus type K-specific transcripts in testicular parenchyma and testicular germ cell tumors of adolescents and adults: clinical and biological implications.

Authors:  H Roelofs; R J van Gurp; J W Oosterhuis; L H Looijenga
Journal:  Am J Pathol       Date:  1998-10       Impact factor: 4.307

2.  Identical allelic losses in mature teratoma and other histologic components of malignant mixed germ cell tumors of the testis.

Authors:  Kevin M Kernek; Thomas M Ulbright; Shaobo Zhang; Steven D Billings; Oscar W Cummings; John D Henley; Helen Michael; Matteo Brunelli; Guido Martignoni; Richard S Foster; John N Eble; Liang Cheng
Journal:  Am J Pathol       Date:  2003-12       Impact factor: 4.307

3.  Testicular Germ Cell Tumors Acquire Cisplatin Resistance by Rebalancing the Usage of DNA Repair Pathways.

Authors:  Cinzia Caggiano; Francesca Cavallo; Teresa Giannattasio; Gioia Cappelletti; Pellegrino Rossi; Paola Grimaldi; Darren R Feldman; Maria Jasin; Marco Barchi
Journal:  Cancers (Basel)       Date:  2021-02-13       Impact factor: 6.639

Review 4.  Mechanisms of TP53 Pathway Inactivation in Embryonic and Somatic Cells-Relevance for Understanding (Germ Cell) Tumorigenesis.

Authors:  Dennis M Timmerman; Tessa L Remmers; Sanne Hillenius; Leendert H J Looijenga
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.